Showing results (1471-1480 of 1,665) with videos related to

Sort By:
Pageof 167
JACC. Cardiovascular Imaging|July 18, 2009
In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL studySergio Waxman, Simon R Dixon, Philippe L'Allier, et al.
Journal of the International Neuropsychological Society : JINS|May 6, 2021
Feasibility and Acceptance of Direct-to-Home Tele-neuropsychology Services during the COVID-19 PandemicMichael W Parsons, Melissa M Gardner, Janet C Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
C-reactive protein as a marker of melanoma progressionShenying Fang, Yuling Wang, Dawen Sui, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Transient Dietary Changes Modulate Inflammatory Disease Trajectory in the Lean StateZewen Jiang, John M Tayeri, Chihiro Tabuchi, et al.
Elife|October 18, 2022
Tissue-specific mitochondrial HIGD1C promotes oxygen sensitivity in carotid body chemoreceptorsAlba Timón-Gómez, Alexandra L Scharr, Nicholas Y Wong, et al.
Cancer Research|February 28, 2024
Bile Acid Metabolism Mediates Cholesterol Homeostasis and Promotes Tumorigenesis in Clear Cell Renal Cell CarcinomaRomain Riscal, Sarah M Gardner, Nathan J Coffey, et al.
Nature Cell Biology|February 6, 2024
Epithelial zonation along the mouse and human small intestine defines five discrete metabolic domainsRachel K Zwick, Petr Kasparek, Brisa Palikuqi, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Epithelial zonation along the mouse and human small intestine defines five discrete metabolic domainsRachel K Zwick, Petr Kasparek, Brisa Palikuqi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive ProteinShenying Fang, Dawen Sui, Yuling Wang, et al.
Leukemia|May 4, 2018
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Emily M Huebner, et al.
Pageof 167